COYA vs EXC · rev $7.9M vs P/E 17, rev $24.26B
Coya Therapeutics, Inc. Common Stock (COYA) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
COYA currently screens at market cap $118.0M. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the COYA and EXC stock pages for the full models.
Not investment advice.